Norketotifen for the Treatment of Uncomplicated Influenza-like Illness
Public ClinicalTrials.gov record NCT04043923. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2b Double-blind, Randomized, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of Norketotifen (NKT) in the Treatment of Acute Uncomplicated Influenza-like Illness (ILI)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2b, multi-center, double-blind, randomized, placebo-controlled, parallel-group study of NKT versus placebo in otherwise healthy adults presenting with acute uncomplicated ILI due to influenza or other respiratory viruses in a community setting.
Study identification
- NCT ID
- NCT04043923
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 238 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 21, 2019 (Actual)
- Primary completion
- Apr 5, 2020 (Actual)
- Completion
- Apr 20, 2020 (Actual)
- Last update posted
- Mar 24, 2021
2019 – 2020
United States locations
- U.S. sites
- 18
- U.S. states
- 10
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cahaba Research | Birmingham | Alabama | 35235 | — |
| Precision Trials AZ | Phoenix | Arizona | 85032 | — |
| Long Beach Clinical Trial Services | Long Beach | California | 90806 | — |
| Empire Clinical Research | Pomona | California | 91767 | — |
| Northern California Research | Sacramento | California | 95821 | — |
| AFC Urgent Care | Denver | Colorado | 80246 | — |
| South Florida Research Center | Miami | Florida | 33135 | — |
| Premier Research Associate | Miami | Florida | 33165 | — |
| Gulfcoast Medical Research | Tampa | Florida | 33607 | — |
| DelRicht Research | Baton Rouge | Louisiana | 70809 | — |
| DelRicht Research | New Orleans | Louisiana | 70124 | — |
| The Clinical Research Center | St Louis | Missouri | 63141 | — |
| OnSite Clinical Solutions | Charlotte | North Carolina | 28277 | — |
| Health Concepts | Rapid City | South Dakota | 57702 | — |
| Premier Family Physicians | Austin | Texas | 78735 | — |
| Family Medicine Associates of Texas | Carrollton | Texas | 75010 | — |
| CityDoc Urgent Care | Dallas | Texas | 75204 | — |
| Village Health Partners | Plano | Texas | 75024 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04043923, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 24, 2021 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04043923 live on ClinicalTrials.gov.